Related Experiment Videos
Neuropeptide Y immunoreactivity in human cerebrospinal fluid
Peptides
|May 1, 1986
Summary
Neuropeptide Y (NPY) levels in human cerebrospinal fluid (CSF) were measured. Researchers found consistent NPY levels across different CSF samples, indicating no significant rostro-caudal gradient.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Neuropeptide Y (NPY) is a peptide neurotransmitter involved in various physiological processes.
- Understanding NPY distribution in human cerebrospinal fluid (CSF) is crucial for neurological research.
Purpose of the Study:
- To quantify Neuropeptide Y (NPY) levels in human cerebrospinal fluid (CSF).
- To investigate the presence of a rostro-caudal gradient for NPY within the CSF.
Main Methods:
- Human cerebrospinal fluid (CSF) samples were analyzed for Neuropeptide Y (NPY) immunoreactivity.
- High-pressure liquid chromatography (HPLC) was employed to confirm the identity of NPY.
- Sequential aliquots of CSF were tested to assess regional differences.
Main Results:
- NPY immunoreactivity in human CSF co-eluted with authentic NPY, confirming its presence.
- The mean NPY level in normal subjects was 108 +/- 18 pg/ml.
- No significant differences in NPY levels were found between sequential CSF aliquots, refuting a rostro-caudal gradient.
Conclusions:
- This study establishes baseline levels of Neuropeptide Y (NPY) in human cerebrospinal fluid (CSF).
- The findings suggest a uniform distribution of NPY within the CSF, with no evidence of a rostro-caudal gradient.